Glenmark’s US arm settles generic drug pricing case for $29.6 million

Glenmark’s US arm settles generic drug pricing case for $29.6 million

Glenmark Pharmaceuticals said its US subsidiary has agreed to pay $29.628 million (approximately ₹284 crore) to settle antitrust and consumer protection litigation linked to allegations of generic drug price-fixing in the United States. The settlement involves Glenmark Pharmaceuticals Inc., USA and a group of state attorneys general in the US. The amount will be paid…

Read More
Defence, exports and platform companies among top market themes: Envision’s Nilesh Shah

Defence, exports and platform companies among top market themes: Envision’s Nilesh Shah

Envision Capital founder Nilesh Shah believes India’s new-age platform companies are entering a multi-year growth cycle similar to the IT services boom of the 1990s, with strong earnings growth, improving cash flows and a sharper focus on profitability despite sharp stock price corrections. He says several internet, fintech and consumer-tech businesses continue to grow at…

Read More
Investment Strategy at 50: Lump Sum or SIP? 9 funds recommended by expert to plan smart and balance risk - Mutual Funds

Divi’s Laboratories Q4 results FY26: 1500% dividend announced; profit up 13.4% YoY to Rs 751 cr, revenue rises 9.5% YoY – Record date, quarterly earnings details – Markets

Divi’s Laboratories dividend 2026: Divi’s Laboratories today declared a 1500 per cent dividend for its shareholders. Divi’s Laboratories Q4 results FY26: Divi’s Laboratories today announced its earnings for the fourth quarter of the financial year 2025-26 and also declared a 1500 per cent dividend for its shareholders. Divi’s Laboratories Dividend 2026 Stock Performance Summary How…

Read More
BCA says the stock and bond markets 'are on a collision course.' And bonds may win

BCA says the stock and bond markets ‘are on a collision course.’ And bonds may win

Bond investors may come out on top as equity and Treasury markets head for a collision. Stock and bond investors are heading for a clash — and the latter may come out on top, according to BCA Research. Continue Reading with CNBC-TV18 Access Membership Priority Access and Networking: CNBC-TV18’s flagship events Interaction with CNBC-TV18’s journalists…

Read More